Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial - Ogawa, H; Nakayama, M; Morimoto, T (JAMA, 2008)
, et al; Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) Trial Investigators.